ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business

IndieBio wants to do for biotech what accelerators have done for IT

IndieBio, a San Francisco-based biotech accelerator, is bringing the biohacker movement to life. In the words of co-founder Ryan Bethencourt: "It was the right time to start a commercial biotech accelerator focused on biology as a technology, not just on the biomedical vertical."

     IndieBio was founded in late 2014 by Arvind Gupta, Ron Shigeta and Bethencourt, backed by SOSV, an accelerator venture capital fund with $250 million in assets under management. Alongside IndieBio, Ireland-based SOSV is also backing vertical accelerators (i.e., organizations focused on helping startups in a particular industry) with a strong presence in Asia. Examples include hardware-focused HAX Accelerator in Shenzhen, MOX, a mobile-only accelerator in Taipei and Chinaccelerator in Shanghai.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more